Virginia Ruth Sanzone Sells 1,903 Shares of ICU Medical Inc. (ICUI) Stock
ICU Medical Inc. (NASDAQ:ICUI) VP Virginia Ruth Sanzone sold 1,903 shares of the stock in a transaction that occurred on Monday, September 12th. The shares were sold at an average price of $121.29, for a total value of $230,814.87. Following the transaction, the vice president now owns 3,049 shares of the company’s stock, valued at $369,813.21. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Shares of ICU Medical Inc. (NASDAQ:ICUI) opened at 122.30 on Monday. ICU Medical Inc. has a 12-month low of $85.56 and a 12-month high of $128.93. The stock has a market cap of $1.97 billion, a price-to-earnings ratio of 36.42 and a beta of 0.49. The company’s 50-day moving average price is $122.38 and its 200 day moving average price is $108.42.
ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Monday, August 8th. The company reported $1.15 EPS for the quarter, beating the Zacks’ consensus estimate of $1.05 by $0.10. The business earned $96.70 million during the quarter, compared to analysts’ expectations of $89.66 million. ICU Medical had a return on equity of 10.33% and a net margin of 14.94%. The business’s revenue was up 15.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.97 earnings per share. On average, equities analysts predict that ICU Medical Inc. will post $4.54 earnings per share for the current year.
A number of research firms have recently commented on ICUI. Piper Jaffray Cos. reiterated a “neutral” rating and set a $119.00 target price (up from $115.00) on shares of ICU Medical in a research report on Thursday, August 11th. Zacks Investment Research upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $140.00 price target on the stock in a report on Friday, August 12th.
Several hedge funds have recently bought and sold shares of ICUI. Mason Street Advisors LLC acquired a new stake in ICU Medical during the second quarter worth approximately $319,000. Royal Bank of Canada boosted its stake in ICU Medical by 57.2% in the second quarter. Royal Bank of Canada now owns 207,226 shares of the company’s stock worth $23,365,000 after buying an additional 75,396 shares during the period. Schwab Charles Investment Management Inc. boosted its stake in ICU Medical by 4.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 48,889 shares of the company’s stock worth $5,513,000 after buying an additional 2,004 shares during the period. Stifel Financial Corp boosted its stake in ICU Medical by 10.9% in the second quarter. Stifel Financial Corp now owns 67,649 shares of the company’s stock worth $7,627,000 after buying an additional 6,656 shares during the period. Finally, Amalgamated Bank acquired a new stake in ICU Medical during the second quarter worth approximately $214,000. Institutional investors and hedge funds own 89.50% of the company’s stock.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.